WASHINGTON, Feb. 11 -- Food and Drug Administration has issued a notice called: Voluntary Quality Management Maturity Prototype Assessment Protocol Evaluation Program.
The notice was published in the Federal Register on Feb. 11 by Lowell M. Zeta, Acting Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA) is announcing an opportunity for a limited number of drug manufacturing establishments to participate in the third year of the voluntary Quality Management Maturity (QMM) Prototype Assessment Protocol Evaluation Program. The Center for Drug Evaluation and Research (CDER) is implementing this voluntary program for manufacturers of CDER-regulated drug products to gain addit...